Literature DB >> 393442

Antibodies directed against renal collecting ducts in sera of human renal allograft recipients.

L C Paul, L A Van Es, M W Kalff, G J Fleuren.   

Abstract

Anatibodies directed against the plasma membrane of renal collecting ducts were found in the sera of two out of 101 renal allograft recipients. The sera also reacted with the epithelium of the renal pelvis, the ureter, the ductus deferens, the skin, the oesophagus, the trachea and the bile ducts of random individuals, indicating that the antibodies were directed against a widespread epithelial antigen. The antibody activity against these structures was removed by absorption of the sera with homogenized renal medullary tissue; absorption with plasma proteins, erythrocytes, spleen leucocytes or platelets did not influence the antibody titers. In the two patients with circulating antibodies, the graft function was unremarkable eight and fifteen months after transplantation, respectively. From this study we conclude that circulating epithelial antibodies directed against the collecting ducts of the graft are of little or no clinical importance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393442      PMCID: PMC1537855     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Blood group B antigen on renal endothelium as the target for rejection in an ABO-incompatible recipient.

Authors:  L C Paul; L A van Es; G B Riviere; G Eernisse; J de Graeff
Journal:  Transplantation       Date:  1978-10       Impact factor: 4.939

2.  Intrarenal distribution of endothelial antigens recognized by antibodies from renal allograft recipients.

Authors:  L C Paul; L A van Es; M W Kalff; J de Graeff
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

3.  Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes.

Authors:  L C Paul; F H Claas; L A van Es; M W Kalff; J de Graeff
Journal:  N Engl J Med       Date:  1979-05-31       Impact factor: 91.245

4.  HLA antigens in kidney tissue. Localisation by means of immunofluorescence technique.

Authors:  J P Sybesma; L Kater; E Borst-Eilers; B A de Planque; T van Soelen; G Tuit
Journal:  Transplantation       Date:  1974-06       Impact factor: 4.939

5.  A heterophile system in human renal transplantation. 3. The HT-A specificities.

Authors:  J C McDonald; G N Mukherjee
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

6.  A naturally occurring human antibody to loops of Henle.

Authors:  P M Ford
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

7.  "Hyperacute" renal-homograft rejection in man.

Authors:  G M Williams; D M Hume; R P Hudson; P J Morris; K Kano; F Milgrom
Journal:  N Engl J Med       Date:  1968-09-19       Impact factor: 91.245

8.  Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts.

Authors:  L C Paul; L A van Es; J J van Rood; A van Leeuwen; G B de la Rivière; J de Graeff
Journal:  Transplantation       Date:  1979-03       Impact factor: 4.939

9.  Identification of I/i, Pr1-3 and Gd antigens in the human kidney: possible relevance to hyperacute graft rejection induced by cold agglutinins.

Authors:  V Lenhard; H P Seelig; H P Geisen; D Roelcke
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

10.  The histological distribution of blood group substances A and B in man.

Authors:  A E SZULMAN
Journal:  J Exp Med       Date:  1960-06-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Autoantibody against fibroblasts in renal transplant recipients: analysis by 51Cr-release assays.

Authors:  M Aprile; P Halloran; G Haddad; M Robinette
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.